Can neoadjuvant chemotherapy be replaced with immune checkpoint blockade combined with dual anti-HER2 antibodies for HER2-enriched breast cancer?
@article{TBCR112512,
author = {Harry D. Bear},
title = {Can neoadjuvant chemotherapy be replaced with immune checkpoint blockade combined with dual anti-HER2 antibodies for HER2-enriched breast cancer?},
journal = {Translational Breast Cancer Research},
volume = {7},
number = {0},
year = {2026},
keywords = {},
abstract = {},
issn = {2218-6778}, url = {https://tbcr.amegroups.org/article/view/112512}
}